Pantoprazole EG Conseil 20 mg - 7 gastro-resistant tablets

Description

Medicinal products for acid disorders, Proton pump inhibitors, ATC code: A02BC02.

Pantoprazole EG Conseil 20 mg contains an active substance, pantoprazole, which reduces the amount of acid produced in the stomach by blocking the ‘proton pump’. It therefore reduces the amount of acid in your stomach.

Pantoprazole EG Conseil 20 mg is used for the short-term treatment of symptoms of gastro-oesophageal reflux disease (e.g. heartburn, acid regurgitation) in adults.

Gastro-oesophageal reflux disease (GERD) is the backflow of acid from the stomach into the oesophagus, which can become inflamed and painful. This can cause symptoms such as a burning sensation in the chest going up to the throat (pyrosis) and a sour taste in the mouth (acid regurgitation).

Acid reflux and heartburn may disappear after one day's treatment with Pantoprazole EG Conseil 20 mg. However, this medicine is not intended to provide immediate relief. It may be necessary to continue treatment for 2 or 3 consecutive days for symptoms to improve.

You should contact your doctor if you do not feel any improvement or if you feel less well after 2 weeks.

Directions for use

The recommended dose is one tablet a day. Do not exceed this recommended dose of 20 mg pantoprazole per day.

Composition

- The active substance is :

Pantoprazole (in the form of pantoprazole sodium sesquihydrate).................................... 20 mg For one gastro-resistant tablet.

- The other components are :

Core: Maltitol (E965), crospovidone type B, sodium carmellose, sodium carbonate, calcium stearate.

Tablet coating: Polyvinyl alcohol, talc, titanium dioxide (E171), macrogol 3350, soya lecithin, yellow iron oxide (E172), sodium carbonate, copolymer of methacrylic acid and ethyl acrylate (1:1), sodium lauryl sulphate, polysorbate 80, triethyl citrate.

Precautions for use

PANTOPRAZOLE EG LABO should not be administered to children and adolescents under 18 years of age in the absence of data on safety in this younger population.

Other medicinal products and PANTOPRAZOLE EG LABO 20 mg, gastro-resistant tablet

Tell your doctor or pharmacist if you are taking, have recently taken or may take any other medicines.

PANTOPRAZOLE EG LABO may prevent certain other medicines from working properly. In particular, medicines containing any of the following active substances:

- HIV protease inhibitors such as atazanavir, nelfinavir (for the treatment of HIV infection). You should not use PANTOPRAZOLE EG LABO if you are taking HIV protease inhibitors. See "DO NOT take PANTOPRAZOLE".PANTOPRAZOLE EG LABO

- ketoconazole (used to treat fungal infections) ;

- warfarin and phenprocoumon (used to reduce blood clotting and prevent the formation of blood clots). Additional blood tests may be required;

- methotrexate (used to treat rheumatoid arthritis, psoriasis and cancer) - if you are taking methotrexate, your doctor may temporarily stop your treatment with PANTOPRAZOLE EG LABO as pantoprazole may increase the levels of methotrexate in your blood. Do not take PANTOPRAZOLE EG LABO with other medicines that limit the amount of acid produced by the stomach, such as another proton pump inhibitor (omeprazole, lansoprazole or rabeprazole) or an anti-H2 drug (e.g. ranitidine, famotidine).

Pregnancy and breast-feeding

Do not take PANTOPRAZOLE EG LABO if you are pregnant or breast-feeding. If you are pregnant or breast-feeding, think you may be pregnant or are planning to become pregnant, ask your doctor or pharmacist for advice before taking this medicine.